Complement activation as a biomarker for Alzheimer's disease

被引:51
作者
Aiyaz, Mohammed [1 ]
Lupton, Michelle K. [1 ]
Proitsi, Petroula [1 ]
Powell, John F. [1 ]
Lovestone, Simon [1 ]
机构
[1] Kings Coll London, Inst Psychiat, London SE5 8AF, England
关键词
Alzheimer's disease; Biomarker; Blood; Complement; Genetic risk factors; Inflammation; Plasma; C-REACTIVE PROTEIN; FACTOR-H POLYMORPHISM; GENOME-WIDE ASSOCIATION; AGE-RELATED MACULOPATHY; CEREBROSPINAL-FLUID; MACULAR DEGENERATION; APOLIPOPROTEIN-E; RECEPTOR; PLASMA BIOMARKERS; ALPHA; 1-ANTICHYMOTRYPSIN;
D O I
10.1016/j.imbio.2011.07.023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is increasing evidence from genetic, immunohistochemical, proteomic and epidemiological studies as well as in model systems that complement activation has an important role in the pathogenesis of Alzheimer's disease (AD). The complement cascade is an essential element of the innate immune response. In the brain complement proteins are integral components of amyloid plaques and complement activation occurs at the earliest stage of the disease. The complement cascade has been implicated as a protective mechanism in the clearance of amyloid, and in a causal role through chronic activation of the inflammatory response. In this review we discuss the potential for complement activation to act as a biomarker for AD at several stages in the disease process. An accurate biomarker that has sufficient predictive, diagnostic and prognostic value would provide a significant opportunity to develop and test for effective novel therapies in the treatment of AD. (C) 2011 Elsevier GmbH. All rights reserved.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 159 条
[61]   Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb [J].
Hourcade, DE ;
Mitchell, L ;
Kuttner-Kondo, LA ;
Atkinson, JP ;
Medof, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1107-1112
[62]   Proteome-based plasma biomarkers for Alzheimer's disease [J].
Hye, A. ;
Lynham, S. ;
Thambisetty, M. ;
Causevic, M. ;
Campbell, J. ;
Byers, H. L. ;
Hooper, C. ;
Rijsdijk, F. ;
Tabrizi, S. J. ;
Banner, S. ;
Shaw, C. E. ;
Foy, C. ;
Poppe, M. ;
Archer, N. ;
Hamilton, G. ;
Powell, J. ;
Brown, R. G. ;
Sham, P. ;
Ward, M. ;
Lovestone, S. .
BRAIN, 2006, 129 :3042-3050
[63]   Absence of association of α1-antichymotrypsin polymorphisms with Alzheimer's disease:: A report on autopsy-confirmed cases [J].
Itabashi, S ;
Arai, H ;
Matsui, T ;
Matsushita, S ;
Muramatsu, T ;
Higuchi, S ;
Trojanowski, JQ ;
Sasaki, H .
EXPERIMENTAL NEUROLOGY, 1998, 151 (02) :237-240
[64]   Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia [J].
Jack, CR ;
Dickson, DW ;
Parisi, JE ;
Xu, YC ;
Cha, RH ;
O'Brien, PC ;
Edland, SD ;
Smith, GE ;
Boeve, BF ;
Tangalos, EG ;
Kokmen, E ;
Petersen, RC .
NEUROLOGY, 2002, 58 (05) :750-757
[65]   Susceptibility genes for age-related maculopathy on chromosome 10q26 [J].
Jakobsdottir, J ;
Conley, YP ;
Weeks, DE ;
Mah, TS ;
Ferrell, RE ;
Gorin, MB .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (03) :389-407
[66]   C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes [J].
Jakobsdottir, Johanna ;
Conley, Yvette P. ;
Weeks, Daniel E. ;
Ferrell, Robert E. ;
Gorin, Michael B. .
PLOS ONE, 2008, 3 (05)
[67]   ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages [J].
Jehle, Andreas W. ;
Gardai, Shyra J. ;
Li, Suzhao ;
Linsel-Nitschke, Patrick ;
Morimoto, Konosuke ;
Janssen, William J. ;
Vandivier, R. William ;
Wang, Nan ;
Greenberg, Steven ;
Dale, Benjamin M. ;
Qin, Chunbo ;
Henson, Peter M. ;
Tall, Alan R. .
JOURNAL OF CELL BIOLOGY, 2006, 174 (04) :547-556
[68]   A potential role for immune complex pathogenesis in drusen formation [J].
Johnson, LV ;
Ozaki, S ;
Staples, MK ;
Erickson, PA ;
Anderson, DH .
EXPERIMENTAL EYE RESEARCH, 2000, 70 (04) :441-449
[69]   Complement activation and inflammatory processes in drusen formation and age related macular degeneration [J].
Johnson, LV ;
Leitner, WP ;
Staples, MK ;
Anderson, DH .
EXPERIMENTAL EYE RESEARCH, 2001, 73 (06) :887-896
[70]   Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease [J].
Jones, Lesley ;
Holmans, Peter A. ;
Hamshere, Marian L. ;
Harold, Denise ;
Moskvina, Valentina ;
Ivanov, Dobril ;
Pocklington, Andrew ;
Abraham, Richard ;
Hollingworth, Paul ;
Sims, Rebecca ;
Gerrish, Amy ;
Pahwa, Jaspreet Singh ;
Jones, Nicola ;
Stretton, Alexandra ;
Morgan, Angharad R. ;
Lovestone, Simon ;
Powell, John ;
Proitsi, Petroula ;
Lupton, Michelle K. ;
Brayne, Carol ;
Rubinsztein, David C. ;
Gill, Michael ;
Lawlor, Brian ;
Lynch, Aoibhinn ;
Morgan, Kevin ;
Brown, Kristelle S. ;
Passmore, Peter A. ;
Craig, David ;
McGuinness, Bernadette ;
Todd, Stephen ;
Holmes, Clive ;
Mann, David ;
Smith, A. David ;
Love, Seth ;
Kehoe, Patrick G. ;
Mead, Simon ;
Fox, Nick ;
Rossor, Martin ;
Collinge, John ;
Maier, Wolfgang ;
Jessen, Frank ;
Schuermann, Britta ;
van den Bussche, Hendrik ;
Heuser, Isabella ;
Peters, Oliver ;
Kornhuber, Johannes ;
Wiltfang, Jens ;
Dichgans, Martin ;
Froelich, Lutz ;
Hampel, Harald .
PLOS ONE, 2010, 5 (11)